1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NuVasive, Inc.
  6. News
  7. Summary
    NUVA   US6707041058

NUVASIVE, INC.

(NUVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NUVASIVE, INC.
05/12NuVasive, Inc. Announces Management Changes
CI
05/06Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Ra..
MT
05/05RBC Capital Adjusts NuVasive's Price Target to $63 From $60, Maintains Outperform Ratin..
MT
05/05Wells Fargo Adjusts NuVasive's Price Target to $62 From $58, Reiterates Overweight Rati..
MT
05/05Needham Raises NuVasive's Price Target to $67 From $64, Reiterates Buy Rating
MT
05/04NUVASIVE : Q1 Earnings Snapshot
AQ
05/04NuVasive Logs Upbeat Q1 Results, Lifts FY22 Guidance
MT
05/04Earnings Flash (NUVA) NUVASIVE Reports Q1 EPS $0.54, vs. Street Est of $0.39
MT
05/04Earnings Flash (NUVA) NUVASIVE Posts Q1 Revenue $290.8M, vs. Street Est of $277.6M
MT
05/04TRANSCRIPT : NuVasive, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04NuVasive Announces First Quarter 2022 Financial Results
PR
05/04NuVasive, Inc. Revises Earnings Guidance for the Full Year of 2022
CI
05/04NuVasive, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/21NUVASIVE SIMPLIFY CERVICAL DISC TWO- : Spine
PR
04/21NUVASIVE, INC. ANNOUNCES THE NUVASIV : Spine
CI
More most relevant news
All news about NUVASIVE, INC.
05/12NUVASIVE INC : Change in Directors or Principal Officers, Submission of Matters to a Vote ..
AQ
05/12NuVasive, Inc. Announces Management Changes
CI
05/06Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Ra..
MT
05/05RBC Capital Adjusts NuVasive's Price Target to $63 From $60, Maintains Outperform Ratin..
MT
05/05Wells Fargo Adjusts NuVasive's Price Target to $62 From $58, Reiterates Overweight Rati..
MT
05/05Needham Raises NuVasive's Price Target to $67 From $64, Reiterates Buy Rating
MT
05/04NUVASIVE : Q1 Earnings Snapshot
AQ
05/04NuVasive Logs Upbeat Q1 Results, Lifts FY22 Guidance
MT
05/04Earnings Flash (NUVA) NUVASIVE Reports Q1 EPS $0.54, vs. Street Est of $0.39
MT
05/04Earnings Flash (NUVA) NUVASIVE Posts Q1 Revenue $290.8M, vs. Street Est of $277.6M
MT
More news
News in other languages on NUVASIVE, INC.
05/12NuVasive, Inc. annonce des changements de direction
05/04NuVasive enregistre des résultats optimistes au premier trimestre et revoit ses prévisi..
05/04Earnings Flash (NUVA) NUVASIVE affiche un chiffre d'affaires de 290,8 millions de dolla..
05/04NuVasive, Inc. révise ses prévisions de bénéfices pour l'année 2022
05/04NuVasive, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2022
04/21NUVASIVE, INC. ANNONCE QUE LES DONNÉ : Spine
04/14Berkeley Lights nomme Lucas Vitale au nouveau poste de directeur des RH
03/28Les actions de NuVasive augmentent après que Wells Fargo ait commencé à les couvrir
02/23NUVASIVE : baisse du BPA ajusté au 4e trimestre, hausse des ventes
02/23NuVasive, Inc. annonce ses résultats pour l'exercice complet clos le 31 décembre 2021
More news
Analyst Recommendations on NUVASIVE, INC.
05/06Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Ra..
MT
05/05RBC Capital Adjusts NuVasive's Price Target to $63 From $60, Maintains Outperform Ratin..
MT
05/05Wells Fargo Adjusts NuVasive's Price Target to $62 From $58, Reiterates Overweight Rati..
MT
05/05Needham Raises NuVasive's Price Target to $67 From $64, Reiterates Buy Rating
MT
04/13Truist Securities Adjusts NuVasive's Price Target to $65 From $60, Reiterates Buy Ratin..
MT
More recommendations
Press releases
05/12NUVASIVE INC : Change in Directors or Principal Officers, Submission of Matters to a Vote ..
AQ
05/04NUVASIVE : Q1 Earnings Snapshot
AQ
05/04NUVASIVE INC Management's Discussion and Analysis of Financial Condition and Results o..
AQ
05/04NUVASIVE INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi..
AQ
05/04NuVasive Announces First Quarter 2022 Financial Results
PR
More press releases